Testing Blood Clotting in Pregnant Women With Low Platelets
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and about to deliver, or have just delivered
- You have a low platelet count (below 120) before delivery, OR you had heavy bleeding after delivery (more than 1500 mL of blood loss) with concerns about low platelets
- You are at least 18 years old
- You are willing to participate and provide consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special blood test to create a score that predicts bleeding risk in patients with blood cancers and very low platelet counts. It could help doctors decide if you need extra care to prevent bleeding.
This study is testing whether giving smaller volumes of platelet transfusions to premature babies with very low platelet counts is as effective as the standard larger volume. It aims to find a safer way to prevent bleeding while reducing risks like fluid overload.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This study looks at how very low platelet levels (and platelet transfusions, if needed) affect bleeding and inflammation in newborns. It may help doctors better understand which newborns are at higher risk and how to manage low platelets.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.